111, Inc. (NASDAQ:YI) Short Interest Update

111, Inc. (NASDAQ:YIGet Free Report) was the recipient of a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 15,200 shares, a decrease of 49.0% from the March 31st total of 29,800 shares. Based on an average daily trading volume, of 65,600 shares, the short-interest ratio is presently 0.2 days.

Hedge Funds Weigh In On 111

A hedge fund recently bought a new stake in 111 stock. Tower Research Capital LLC TRC purchased a new position in shares of 111, Inc. (NASDAQ:YIFree Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 18,558 shares of the company’s stock, valued at approximately $29,000. Institutional investors own 21.32% of the company’s stock.

111 Trading Down 3.8 %

Shares of YI opened at $1.01 on Friday. The firm has a market capitalization of $84.35 million, a price-to-earnings ratio of -1.55 and a beta of 0.38. The firm’s fifty day simple moving average is $1.25 and its 200-day simple moving average is $1.64. 111 has a twelve month low of $0.97 and a twelve month high of $3.36.

111 (NASDAQ:YIGet Free Report) last announced its quarterly earnings results on Thursday, March 21st. The company reported ($0.34) earnings per share (EPS) for the quarter. The business had revenue of $578.69 million during the quarter.

About 111

(Get Free Report)

111, Inc, together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers.

Further Reading

Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.